GLOBAL DRUG DELIVERY MARKET FORECAST 2022-2030

January 2022 •
366 pages •
Report ID: 5496011 •
Format: PDF

Summary
Table of contents

KEY FINDINGS
The global drug delivery market is projected to record a CAGR of 6.84% during the estimated years of 2022 to 2030. The market growth is mainly reinforced by the increasing usage of biological drugs, technical advancements in drug delivery techniques, the increasing incidence of chronic conditions and prevailing aging population, as well as the rising need for effective drug delivery mechanisms.

MARKET INSIGHTS
Drug delivery entails the process of administering a pharmaceutical compound in order to provide therapy for various conditions.These drug delivery technologies alter the profile of drug releases, such as distribution, absorption, and elimination for the improvement of product safety and efficacy.

It also considers patient convenience as well as compliance with the drug. The common routes of administration include oral, enteral, inhalation, parenteral, topical, and transdermal patches routes.
Technological advancements in the avenue of drug delivery technology are one of the leading factors propelling the global market’s growth.In addition, the introduction of novel delivery platforms is anticipated to introduce solutions that optimize a drug’s therapeutic value, thus finding a relatively improved approach to get a drug into the patient’s body consistently and safely.

As a result, this aspect leads to improved compliance and outcomes.

REGIONAL INSIGHTS
The global drug delivery market growth assessment includes the analysis of North America, Europe, Asia-Pacific, and Rest of World.The Asia-Pacific is set to grow with the highest CAGR.

The regional market’s growth is attributed to the increasing healthcare awareness, the surge in disposable income and government expenditure, and the rise in healthcare spending. Furthermore, domestic enterprises in the Asia-Pacific are fundamentally engaged in the manufacture of low-costing smart syringes for international as well as local usage.

COMPETITIVE INSIGHTS
The global drug delivery market is competitive, with top players involved in continuous partnership alliances and product development to aid market penetration. Moreover, the increasing number of dealers and distributors is set to elevate industry rivalry over the upcoming years.
Some of the key companies operating in the market are Antares Pharma Inc, Baxter International Inc, Johnson & Johnson, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ALKERMES PLC
2. ANTARES PHARMA INC
3. BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
4. BAXTER INTERNATIONAL INC
5. BAYER AG
6. BECTON, DICKINSON AND COMPANY (BD)
7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8. BOSTON SCIENTIFIC CORPORATION
9. GENEREX BIOTECHNOLOGY CORPORATION
10. GLAXOSMITHKLINE PLC
11. JOHNSON & JOHNSON
12. KINDEVA DRUG DELIVERY (FORMERLY 3M DRUG DELIVERY SYSTEMS)
13. NOVARTIS AG
14. NOVO NORDISK A/S
15. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager